CTOR

Dopo l'orario di chiusura: 1.96 -0.01 -0.51%

Citius Oncology Inc (CTOR)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Citius Oncology Inc Stock (CTOR) Company Profile

Citius Oncology Inc

Healthcare (1164)

(908) 967-6677

11 COMMERCE DRIVE, CRANFORD

Prossima data di guadagno

Ultimi documenti SEC

CTOR's Discussions on Twitter

Confronta CTOR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CTOR Citius Oncology Inc	1.97	152.82M	0	0	0	0.00
ZTS Zoetis Inc	152.12	68.04B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	14.48	46.30B	30.08B	710.16M	4.45B	0.2182
HLN Haleon Plc Adr	9.88	44.25B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.54	18.73B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	304.50	13.82B	2.99B	1.21B	1.13B	25.06

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-27	Iniziato	Maxim Group	Buy

Citius Oncology Inc Borsa (CTOR) Ultime notizie

Citius Oncology Inc Azioni (CTOR) Dati Finanziari

Non sono disponibili dati finanziari per Citius Oncology Inc (CTOR). Controlla altri titoli per ulteriori informazioni.

Citius Oncology Inc (CTOR)

Citius Oncology Inc Stock (CTOR) Company Profile

Confronta CTOR con altri titoli

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Citius Oncology Inc Borsa (CTOR) Ultime notizie

Is Citius Oncology Inc. a good long term investmentExceptional trading performance - Autocar Professional

Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider

Citius Oncology Inc. Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional

What drives Citius Oncology Inc. stock priceConsistently exceptional gains - Autocar Professional

What analysts say about Citius Oncology Inc. stockFree Wealth Management Insights - jammulinksnews.com

Citius Oncology shares rise 1.31% after-hours after closing a $9.0 million public offering. - AInvest

Should I buy Citius Oncology Inc. stock before earningsShort Term High Return Strategy - Newser

Citius Oncology Completes $9M Public Offering - TipRanks

Citius Oncology launches $15M equity and warrant offering; shares down - MSN

Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia

Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com Nigeria

Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest

Citius Oncology Announces Closing Of $9.0 Million Public Offering - Barchart.com

Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛

Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest

Citius Oncology’s Chances: Time to Invest? - StocksToTrade

Citius Oncology Announces Pricing of $9.0 Million Public Offering - Finansavisen

Citius Oncology Soars 35.06% on Distribution Deal - AInvest

Citius Oncology Soars 12.34% on Expanded Lymphir Distribution - AInvest

Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com

What makes Citius Oncology Inc. stock price move sharplySecure Your Capital Strategy - Newser

Why Citius Oncology Inc. stock attracts strong analyst attentionEarly Breakout Tracker - Newser

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st

Citius Oncology Shares Climb Following Expansion of LYMPHIR Distribution Network - MSN

Citius Oncology (CTOR): Is LYMPHIR's Launch Priced for Success? - AInvest

Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha

Citius Pharmaceuticals (CTXR) Surges on New Distribution Deal - GuruFocus

Citius Oncology stock rises after expanding LYMPHIR distribution network By Investing.com - Investing.com South Africa

How Citius Oncology Inc. stock performs during market volatilityLow Risk Entry Points - Newser

Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener

Cencora distribution deal boosts Citius shares - MSN

Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia

Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha

Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com Nigeria

Citius Oncology Inc Azioni (CTOR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CTOR